Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
Lipopolysaccharide-Induced Neuroinflammation
100%
Phosphodiesterase
100%
MPTP-induced Parkinsonism
100%
Parkinson's Disease
100%
Lipopolysaccharide
75%
Antiinflammatory Activity
50%
Binding Protein
25%
Therapeutic Effect
25%
Western Blot
25%
Nervous System Inflammation
25%
Neutrophil Collagenase
25%
Cytokine
25%
Phosphotransferase
25%
Immunoglobulin Enhancer Binding Protein
25%
Transcription Factor Nrf2
25%
Gelatinase B
25%
Tumor Necrosis Factor
25%
Inducible Nitric Oxide Synthase
25%
Cyclooxygenase 2
25%
Dopamine Receptor Stimulating Agent
25%
Stromelysin
25%
Cyclic AMP Dependent Protein Kinase
25%
Huntington Chorea
25%
Interleukin 10
25%
Nitric Oxide
25%
Antioxidant
25%
Interleukin 6
25%
Messenger RNA
25%
Neuroscience
Parkinson's Disease
100%
Lipopolysaccharide
100%
Mitochondrial Permeability Transition Pore
100%
Phosphodiesterase
100%
Anti-Inflammatory
33%
In Vivo
16%
Kinase
16%
MMP9
16%
Striatum
16%
Neuronal Cell Death
16%
Interleukin 10
16%
Tumor Necrosis Factor Alpha
16%
Substantia nigra
16%
Tetrahydropyridine
16%
Western Blot
16%
Proinflammatory Cytokine
16%
Protein Kinase A
16%
Response Element
16%
Dopaminergic
16%
Interleukin 6
16%
Cyclic Adenosine Monophosphate
16%
Nucleus Accumbens
16%
Nitric Oxide
16%
Immunoglobulin Enhancer Binding Protein
16%
Transcription Factor Nrf2
16%
Antioxidant Responsive Element
16%
Amino Terminal Sequence
16%
Protein Binding
16%
Neutrophil Collagenase
16%
Stromelysin
16%
Cyclooxygenase 2
16%
Inducible Nitric Oxide Synthase
16%
Huntington's Disease
16%
Microglia
16%
Messenger RNA
16%
Reverse Transcription Polymerase Chain Reaction
16%